Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

• Published in: Annals of oncology Vol. 31; no. 8; pp. 1065 - 1074
• Main Authors: Sud, A., Jones, M.E., Broggio, J., Loveday, C., Torr, B., Garrett, A., Nicol, D.L., Jhanji, S., Boyce, S.A., Gronthoud, F., Ward, P., Handy, J.M., Yousaf, N., Larkin, J., Suh, Y-E., Scott, S., Pharoah, P.D.P., Swanton, C., Abbosh, C., Williams, M., Lyratzopoulos, G., Houlston, R., Turnbull, C.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.08.2020; The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology
• Subjects: Adult; Aged; Aged, 80 and over; Betacoronavirus; Coronavirus Infections - diagnosis; Coronavirus Infections - epidemiology; Coronavirus Infections - therapy; COVID-19; delay; diagnostics; Female; Hospitalization - trends; Humans; Male; Middle Aged; Neoplasms - diagnosis; Neoplasms - epidemiology; Neoplasms - surgery; oncology; Pandemics - prevention & control; Pneumonia, Viral - diagnosis; Pneumonia, Viral - epidemiology; Pneumonia, Viral - therapy; SARS-CoV-2; survival; Time-to-Treatment - trends; Treatment Outcome; COVID-19; diagnostics; delay; oncology; survival
• ISSN: 0923-7534; 1569-8041; 1569-8041
• DOI: 10.1016/j.annonc.2020.05.009

Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of cancers during delay will impact on patients' long-term survival. We generated per-day hazard ratios of cancer progression from observat...